William Blair Investment Management LLC Makes New Investment in Addus HomeCare Corporation $ADUS

William Blair Investment Management LLC purchased a new position in shares of Addus HomeCare Corporation (NASDAQ:ADUSFree Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 176,206 shares of the company’s stock, valued at approximately $17,703,000. William Blair Investment Management LLC owned 0.94% of Addus HomeCare as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of ADUS. Oregon Public Employees Retirement Fund increased its position in Addus HomeCare by 2.5% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 4,153 shares of the company’s stock worth $446,000 after purchasing an additional 103 shares during the last quarter. ProShare Advisors LLC boosted its holdings in Addus HomeCare by 3.1% in the 4th quarter. ProShare Advisors LLC now owns 3,527 shares of the company’s stock valued at $379,000 after purchasing an additional 105 shares during the last quarter. CANADA LIFE ASSURANCE Co boosted its holdings in Addus HomeCare by 0.6% in the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 18,684 shares of the company’s stock valued at $2,150,000 after purchasing an additional 106 shares during the last quarter. State of Wyoming grew its stake in shares of Addus HomeCare by 25.7% in the 4th quarter. State of Wyoming now owns 523 shares of the company’s stock valued at $56,000 after buying an additional 107 shares during the period. Finally, Pathstone Holdings LLC grew its stake in shares of Addus HomeCare by 0.9% in the 3rd quarter. Pathstone Holdings LLC now owns 12,727 shares of the company’s stock valued at $1,502,000 after buying an additional 112 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Insider Buying and Selling

In other news, insider Heather Brianne Dixon sold 288 shares of the firm’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total transaction of $27,005.76. Following the completion of the transaction, the insider directly owned 44,371 shares in the company, valued at $4,160,668.67. This trade represents a 0.64% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 4.10% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. Weiss Ratings raised shares of Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Royal Bank Of Canada raised their target price on Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 5th. Citizens Jmp restated a “market outperform” rating and issued a $142.00 target price on shares of Addus HomeCare in a research report on Monday, May 18th. Citigroup reaffirmed a “market outperform” rating on shares of Addus HomeCare in a research note on Friday, July 24th. Finally, Barclays increased their price target on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a report on Wednesday, July 8th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $130.88.

View Our Latest Report on ADUS

Addus HomeCare Price Performance

Addus HomeCare stock opened at $120.81 on Friday. The company’s 50 day simple moving average is $109.47 and its 200-day simple moving average is $102.50. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.69 and a current ratio of 1.69. Addus HomeCare Corporation has a 1 year low of $87.95 and a 1 year high of $124.43. The company has a market capitalization of $2.26 billion, a price-to-earnings ratio of 21.19, a price-to-earnings-growth ratio of 1.62 and a beta of 0.87.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last posted its quarterly earnings data on Monday, August 3rd. The company reported $1.73 earnings per share for the quarter, topping analysts’ consensus estimates of $1.70 by $0.03. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The firm had revenue of $377.41 million during the quarter, compared to analysts’ expectations of $376.24 million. During the same quarter last year, the company posted $1.49 EPS. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. As a group, equities research analysts expect that Addus HomeCare Corporation will post 6.29 earnings per share for the current year.

Addus HomeCare Profile

(Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

Featured Stories

Want to see what other hedge funds are holding ADUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Addus HomeCare Corporation (NASDAQ:ADUSFree Report).

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.